In the Mayak Worker Dosimetry System-2013, lung dose is calculated as an average of the three absorbed doses to the bronchial, the bronchiolar and the alveolar regions. Previous epidemiological studies involving Mayak Workers have used a lung dose calculated as the total energy deposited in the lungs divided by the mass. These two definitions lead to very different estimates of lung dose, especially for radon dosimetry. This paper uses the results of recent epidemiological studies to justify the use of a regionally weighted lung dose (w i = 1/3, I = 1, 3) over the use of an 'average lung' dose.
INTRODUCTION
Normally, in epidemiological studies designed to quantify the risk of some harmful effect such as cancer, the role of the internal dosimetrist is to calculate absorbed dose to relevant specific organs for each member of the cohort. The role of the epidemiologist is to quantify the probability of an effect occurring (usually cancer) per unit of absorbed dose by use of a risk model. This risk model may also include factors that affect dose (modifiers), such as time since exposure, dose rate, etc., which are deemed to be important. In the case of the lungs, however, the dosimetric task is complicated because in the Mayak Worker Dosimetry System (MWDS)-2013 model considered here (1) the lungs consist of three distinct regions (the bronchial (BB), the bronchiolar (bb) and the alveolar region (AI)), and although the absorbed dose to each of these regions can be calculated separately, (strictly speaking, it is the absorbed dose to the radiosensitive cells in the region that is calculated), it is extremely unlikely that the risk of developing lung cancer per unit of energy deposited in it would be the same for all three regions.
Furthermore, in the cohort of Mayak workers, there is insufficient health data to distinguish between the different types of cancer that may be caused by irradiation of the different lung regions, and so only one dose to represent 'lung dose' is required. Since the internal dosimetry produces three doses, it logically follows that these doses must be weighted in some way to give one representative dose, D(lung): where D( x ) is the absorbed dose to region x. This paper is concerned with determining the most appropriate values to use for the regional lung weights w i .
Some epidemiological studies on lung cancer risks have used weights which correspond to an overall average lung dose, i.e. total energy emitted divided by total mass of the lungs (2, 3) while others have chosen to use weights which give an equal contribution from the absorbed doses in each region (4) . For this reason, care must be exercised when comparing the results from different epidemiological studies. In a recent paper comparing lung doses and risks from radon and plutonium exposures, it was recommended that regional lung weighting factors should be used for the calculation of lung dose, before any comparisons are made (5) . In this paper, we show that a realistic choice of regional weights is important in the Mayak worker study, and investigate different ways of weighting the lung regions. We also show that the use of an average lung dose leads to conclusions that are inconsistent with the results of current epidemiological studies involving radon. Conversely, the assumption of equal regional weights (w 1 = w 2 = w 3 = 1/3) leads to results that are consistent with current radon epidemiological studies. In the discussion section, other arguments are presented that support the use of equal regional weights.
It should be noted that there are many difficulties not alluded to in this paper, including those associated with modeling different mine atmospheres, the attachment of radon daughters to ambient aerosols, and their corresponding effect on uncertainty. The uncertainty in the corresponding calculation of lung doses is, however, likely to be small compared to other uncertainties discussed in this paper. Therefore, a description of these issues is not included here so as not to distract from the main aim of this paper which is to justify the use of the chosen set of equal regional weights.
DETERMINATION OF REGIONAL WEIGHTING FACTORS

Why the choice of w i is important
Let us assume that the excess risk of developing a lung cancer is proportional to the calculated lung dose. If the values of w i are unrealistic, then the correct increment in lung cancer risk (the sum of the risks from each region) will not be obtained when different lung regions are irradiated to differing extents. However, if the ratio of the doses in each lung region is always the same, then to some extent, the actual values of the lung weights, w i , would not be as important. This is because the calculated dose would always be directly proportional to the true dose (i.e. the dose calculated with the correct weights). This is easily demonstrated. Let us assume that w 1 , w 2 and w 3 are the true weights. Then the true dose D T (lung) is given by:
To investigate the situation where the regional doses are always in the same ratio, let the dose to each region be a fixed fraction of the total dose, D tot . Thus,
where a, b and c are fixed constants (a + b + c = 1) then
Now assume that incorrect weights w 1 ′, w 2 ′ and w 3 ′ are used in the internal dose assessment. Then the assessed dose D A (lung) will be:
i.e. the assessed dose will always be directly proportional to the true dose. This constant of proportionality would of course be inversely reflected in the epidemiological assessment of risk per dose. In other words, the wrong model (w 1 ', w 2 ' and w 3 ') used with the wrong risk per dose, would still lead to the correct risk for any individual. Conversely, if the ratios a, b and c are different for one worker compared to another, then it can be seen that the ratio of the assessed dose to the true dose would be different for that worker. If the correct weights are used, then w i ' = w i , and the assessed dose would be correct whatever the ratios of dose were to each region. In the Mayak workforce, workers are exposed to plutonium oxides, nitrates and sometimes a mixture of the two. A modified version of IMBA Professional Plus (6) was used here to calculate the contribution of the total equivalent dose from each region, following an acute intake of plutonium, and using the default parameter values from MWDS-2013. The results are shown in Table 1 .
It can be seen that the regional distribution of dose is different for oxides and nitrates (and also therefore for mixtures). From the argument above, it follows that in order to avoid a bias in the risk or dose estimates between oxides and nitrates, then the correct w i must be used.
To make this absolutely clear, let us take an extreme example, where, say, the risk of lung cancer is only dependent on the dose to the BB region (w 1 = 1), but that it is wrongly assumed that it is the dose to the AI region only that causes cancers (w 3 ′ = 1). Then for nitrates, the assessed dose would be twice what is should be, and hence the risk per assessed dose would be half the true risk. For oxides, however, the assessed dose would be 15 times too high, and hence the assessed risk would be 15 times too low. Two epidemiological studies, one with a cohort of oxides and one with nitrates would tend to estimate a risk per Gy that differed by a factor 7.5.
This of course is an extreme example, but illustrates that in practice, since the Mayak cohort contains workers exposed to oxides, nitrates and mixtures, it is important for the regional lung weights w i ' to be as realistic as possible, and this is the subject of the next section.
Two options for weighting
There are an infinite number of ways of weighting the regional doses, but two have been used previously.
Average lung dose
Average lung dose is simply the total energy deposited in the lungs divided by the mass of the lung. This dose was used for the calculation of lung dose for the DOSES-2005 (7) and MWDS-2008 (2) . The average lung dose concept was also used in the ICRP Publication 30 lung model (8) . Implicit in this assumption is the idea that the incremental lung cancer risk is independent of where the energy is deposited, i.e. a single alpha particle depositing in any region (BB, bb or AI) will give the same excess risk of lung cancer. However, because the target regions for BB and bb have much smaller masses (grams) than the AI region (1.1 kg), then the dose delivered to them from a unit energy deposited will be much higher, and so the w i for these two regions must be correspondingly lower to give the same risk. In fact it can be shown that calculating the dose to each region and weighting by the factors in Table 2 is mathematically equivalent to calculating the 'average lung dose'.
It can be seen that the average lung dose is almost equal to the AI dose.
ICRP weighted lung dose
ICRP weighted lung dose is simply the average dose to the three regions. It has been used in recent radon epidemiological studies (4) . It is also used for radiological protection purposes and is incorporated in the definition of equivalent dose. Implicit in this assumption is the idea that the incremental lung cancer risk depends equally on doses to all three regions. Under this assumption, an alpha particle deposited in the upper airways (BB or bb) would have a much higher probability of causing a lung cancer than one deposited in the AI region, since the lower masses of BB or bb would result in a much higher dose. This dose corresponds to calculating the dose in each region and multiplying by the w i 's in Table 3 .
Which approach is better?
In order to choose between the two options above, (i.e. which option is likely to be closer to the truth), then recourse must be made to epidemiological data which is outside and independent from that considered in the Mayak cohorts. The overall sensitivity of lung cancer risk to plutonium exposure can be derived from the Mayak worker cohort, but because there are insufficient health data on the different types of lung cancer due to exposure to different lung regions, the sensitivity of the regional doses (w i ) must come from elsewhere.
Studies which cast some light on this are those dealing with radon dosimetry. These studies are suitable for two reasons. Firstly, inhaled radon progeny delivers nearly all of its dose to the BB and bb regions, and this is where the predictions of the two opposing definitions differ most. Secondly, the dose is delivered predominantly by alpha irradiation over a protracted period, the same as for plutonium, and so complicating factors such as uncertainty in Relative Biological Effectiveness (RBE) and dose rate effect are minimized. In this section, lung dose is calculated using both methods, and the resulting radiological risk is compared directly to epidemiological data on miners.
Let us assume that a miner is exposed to 1 Working Level Month (WLM). Note that 1 WLM is a measurement of exposure i.e. concentration of potential alpha energy multiplied by the duration. Then applying the MWDS-2013 model would result in the regional lung doses shown in Column 2 of Table 4 . Applying the regional weights for 'average lung dose' and 'ICRP weighted lung dose', and multiplying by an radiation weighting factor of 20 and a tissue weighting factor of 0.12 gives a very good approximation to the effective dose (mSv) for both models (since the contribution to effective dose is dominated by lung dose).
Because nearly all of the contribution from effective dose arises from the lungs, the risk associated from this dose can be assigned to the risk of lung cancer. ICRP Publication 103 (9) gives a total detriment of 0.0422/Sv for workers. Multiplying this total detriment per Sv by the effective dose per WLM gives the lifetime risk per WLM for lung cancer (Table 5) . Table 3 . Values of the regional lung weights that correspond mathematically to the 'ICRP weighted lung dose'.
It can be seen that the predicted risks according to the two regional weight assumptions differ by a factor of 11. In order to decide which of these predictions is closer to the observed risks, epidemiological studies of miners relating measurements of exposure (WLM) and excess risk of lung cancer must be used.
Earlier estimates of the lifetime excess absolute risk (LEAR) of lung cancer per WLM in ICRP Publication 65 (10) suggested a value of 2.83 10
. However, more recent data, published in the BEIR VI Report including miners not so highly exposed, suggests higher risks per WLM (11) . Interpretation of the BEIR VI data in terms of absolute risk by the U.S. Environmental Protection Agency (12) suggests a risk of 5.38 10
. A similar value of 4.4 10 −4 is derived in a joint French Czech Study (13) . ICRP have recently reviewed studies of the risk per WLM from radon exposure and recommend in Publication 115 (page 44) (14) a rounded value of 5.0 10 . See also Marsh et al. (15) for further discussion of these values. A summary of these more recent estimates are shown in Table 6 .
A comparison of the predicted risk with dosimetry and the actual epidemiological data shows excellent agreement if the lung dose is calculated with the 'weighted lung dose' but predicted risk with average lung dose underestimates by more than an order of magnitude.
DISCUSSION
In the previous section, it is argued that in order to calculate a lung dose that would be unbiased between workers exposed to oxides and those exposed to nitrates, then it is important to use regional weights that are realistic. It was further argued that use of the 'average lung dose' would estimate lung doses from radon exposure, which when combined with standard dosimetric risk factors, would lead to LEAR per WLM that was over an order of magnitude smaller than those derived from direct epidemiological studies. Therefore, a lung dose which takes more account of the energy deposited in the upper airways (BB and bb regions) is more realistic. However, the validity of this argument requires that other uncertainties be also taken into account.
One such source of uncertainty is the RBE for alpha particles. Although a value of 20 is assumed for the radiation weighting factor for alpha particles for radiological protection purposes, this is a judgment value based on the RBE for alpha particles, which is uncertain. If the RBE was in fact higher than is currently estimated, then this would increase both the dosimetric estimates of LEAR. However, for the dosimetric estimate of LEAR calculated using average lung dose to be compatible with the observed epidemiological estimates of risk, the RBE would have to increase to 264.
Another source of uncertainty is the assumed value of 2 for the Dose and Dose Rate Effectiveness Factor (DDREF). Decreasing this factor would tend to increase the LEAR per WLM; however, in practice, the estimates of RBE and DDREF tend to be positively correlated, and so any reduction in its assumed value would have less than a pro rata effect on the dosimetric LEAR.
The tissue weighting factor for lungs is also a source of uncertainty, but while it may be possible to Average lung dose 3.8 × 10
a Lifetime risk per WLM is obtained by multiplying the total detriment/Sv (0.0422/Sv) for workers (9) by the effective dose per WLM (Sv/WLM). increase this by up to a factor of 2 (a value of the relative detriment for lungs for a worker is estimated to be 0.286 by ICRP (9) Another criticism that may apply to our argument is that the LEAR per WLM is highly influenced by smoking habits, and the uncertainty in smoking habits has not been taken into account. Darby et al. (16) calculated that the risk could be 25 times higher in current smokers than for life-long nonsmokers. However, in the risks shown in Table 6 , the population consists of both smokers and nonsmokers, and so one would expect a value somewhere between these two extremes, and therefore it is still highly unlikely that uncertainties due to smoking habit would be able to account for the factor of 11 difference.
An alternative way of investigating the effect of smoking is to consider the excess relative risk per Gray (ERR/Gy). The ERR/Gy is much less sensitive to smoking habit because of the sub-multiplicative effect of smoking and radon. It has been shown (11) that the difference in ERR/Gy between smokers and nonsmokers is much less than for LEAR-around a factor of 2. A similar ratio (1.7) has been obtained in a recent combined European nested case-control miner study (17) . Values for the ERR/Gy, calculated using the ICRP-66 respiratory tract model have been recently published (4, 5) . A modified version of IMBA Professional Plus has been used to re-calculate the lung dose from exposure to 1 WLM, using different dosimetric models, and this has been used to infer the effect on the ERR/Gy that would have resulted if these models had been used in the miner epidemiological analysis. The results for different models are shown in Table 7 .
As argued above, these values are less sensitive to smoking habits than LEAR, but still show a big difference between the models used to calculate dose. It can be seen from Table 7 that the two models using average lung dose, (b) and (d), suggest ERR's/Gy that are much higher than those that use the ICRP weighted lung dose. The ERR/Gy (gamma) from the Life Span Study (LSS) of A-bomb survivors (3) gives values of 0.36 (0.04-0.78) and 0.34 (0.05-0.72) for mortality and incidence of lung cancer, respectively. If an RBE of 20 for alpha particles is assumed, then this would correspond to a value of~7/Gy, which is much closer to models using the ICRP weighted lung dose. Indeed, the RBE would have to be as high as 160 to give results compatible with models (b) and (d)-and RBE values based on animal studies imply much lower values. Hoffmann et al. (19) usefully summarized RBE values for in vitro oncogenic transformations in different immortalized cell lines irradiated by alpha particles. These values ranged from 3 to 20 with an average value of 7. Values ranging from 4 to 8 were reported for lung cancer incidence in rats exposed to radon progeny (20) . Following inhalation of 239 PuO 2 , RBE values of around 20 were determined for the induction of pulmonary tumors in rats (21) and dogs (22) . It can be concluded that the RBE for alpha particles is extremely unlikely to be as high as 160, which is what would be needed to make the ERR for gamma irradiation (from the LSS) compatible with the ERR for radon exposure (using an 'average' lung dose).
Although the effect on lung dose from exposure to radon is significantly influenced by the choice of regional weighting factors, this effect is not so great for exposure to plutonium aerosols. This is because of the different distribution of regional dose between radon and plutonium. A recent analysis of Mayak workers exposed to airborne plutonium (3) has shown an ERR/Gy (calculated using the MWDS-2008 dosimetry system which assumes an average lung dose) of 7.0 (range 4.8-10). If an RBE 20 is used for alpha particles, then this is in excellent agreement with the ERR/Gy observed in the LSS study of 0.35. This has prompted some to argue that because:
(a) gamma rays deposit their energy uniformly throughout the lung; (b) the MWDS-2008 uses the 'average lung dose'; (c) the agreement is so good between the ERRs; (d) then the average lung dose concept must be preferred.
There are however, two important points to consider before such a conclusion can be drawn. The first is that the gamma dose would be exactly the same whatever regional weights are used since the gamma dose to each region is the same and the weights add up to 1. The second point is that lung doses from plutonium are less sensitive to the choice of regional weights than for radon, and so the use of the ICRP regional weights may also lead to ERRs that are consistent between plutonium Table 7 . Estimated values for the ERR/Gy for exposure to radon using different lung models. Values in bold are published values (4) and values in brackets are our inferred values based on the use of different lung models. dosimetry and the LSS. Without actually doing the analysis itself, the ERR/Gy that will be obtained using the MWDS-2013 model on the Mayak data is difficult to infer, since the effect on lung dose will be different for oxides than nitrates and it is difficult to assess the relative importance of workers exposed to each in the actual cohort. Simple calculations based on the dose per unit urine measurement show that use of the MWDS-2013 model would lead to doses that were higher by a factor of around 2.5 for nitrates but lower by a factor 0.7 for oxides, thus it might well be the case that the overall estimate of ERR using the whole cohort and the MWDS-2013 model would also lead to results that were also consistent with the LSS study and an RBE of 20. Since both the use of 'average lung dose' and 'ICRP weighted lung dose' could both give estimates of ERR that are compatible with the LLS (and an RBE of 20), this compatibly cannot be used to infer the preference of using one weighting system over another. This is especially true given the uncertainty in the RBE of alpha particles for lung cancer induction. It can thus be concluded that there is insufficient statistical power in comparisons of ERR in plutonium dosimetry with ERRs from gamma dosimetry in the LLS study to draw conclusions about which regional lung weights are appropriate to use. Instead, use must be made of radon dosimetry and epidemiology, which clearly show that the assumption of an average lung dose is inconsistent with the observed risk of lung cancers in workers exposed to radon.
The fact that an average lung dose cannot be used for radon dosimetry is not new but sometimes forgotten. This was precisely the reason why radon was never included in the list of radionuclides dealt with by the ICRP Publication 30 lung model (8) , which used an average lung dose. Instead, radon dosimetry use a dosimetry model described in ICRP Publication 32 (23) which employed regional weights (0.5 being assigned to the upper airways and 0.5 to the lower airways). The introduction of regional weighting factors (called apportionment factors) in the ICRP Publication 66 (18) model was designed with the specific aim of unifying the treatment of all radionuclides.
Although it has been clearly demonstrated that a comparison of radon epidemiology with the LSS study clearly favors weighting factors that are close to the ICRP weighting factors (w i = 1/3) and is inconsistent with those weighting factors corresponding to an average lung dose (w 3 = 1), it may be that other choices of weighting factors are possible. While this is acknowledged, any such choice of w i must be at least close to the ICRP weights (e.g. w 1 = 0.25, w 2 = 0.25, w 3 = 0.5). It is also clear, that given the uncertainties in the range of ERR/Gy, that the use of any other such weights could not be favored statistically over the current ICRP (w i = 1/3) values. This, combined with the fact that w i = 1/3 is also currently used in the current system of radiological protection, to assign 'lung doses' to workers and also used for calculation of lung doses in compensation schemes involving lung cancer, makes it an ideal choice for the definition of lung dose. To have a 'lung dose' for epidemiologists, who derive an excess risk per 'lung dose', that is derived differently than 'lung dose' calculated in radiological protection, can only be a recipe for confusion.
CONCLUSION
It has been shown that the choice of how to weight the regional absorbed lung doses calculated by dosimetry is very important, and if the weights (w i ) are chosen incorrectly, then this would lead to a bias between the lung doses of workers exposed to plutonium nitrates from those exposed to oxides.
Previous epidemiological studies on Mayak Workers have used an average lung dose defined as the total amount of energy deposited in the lungs divided by the total mass. This definition of lung dose effectively ignores any contribution of dose from the upper airways, since it occurs through a small amount of energy being deposited in a small mass. More recent studies have used a regionally adjusted lung dose where w i = 1/3, in line with the definition of equivalent lung dose in the current system of radiological protection and which does attach importance to dose delivered in the upper airways.
This paper has demonstrated that lung dose calculated as an 'average lung dose' leads to risks of lung cancer following exposure to radon that are clearly refuted by current epidemiological studies. Conversely, adoption of the current ICRP regional weighting factors, w i = 1/3, leads to a very good agreement between the risks of lung cancer for workers exposed to radon, and those at risk of lung cancer following gamma irradiation from the LLS studies.
It is therefore concluded, that until more epidemiological evidence becomes available, the most appropriate weights to use for the regional lung dose are w i = 1/3, i = 1,3. Furthermore, this definition of lung dose has the advantage that it is fully consistent with the calculation of equivalent dose in radiation protection practices throughout the world. 
